Zhejiang Leapmotor Technology Co., Ltd. (HKG:9863)

Intercept Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,378	11,731	6,949	4,338	100.81
Short-Term Investments	1,794	965.27	80.82	-	-
Trading Asset Securities	11,473	2,770	929.8	1,260	76.04
Cash & Short-Term Investments	19,645	15,466	7,960	5,598	176.85
Cash Growth	27.02%	94.31%	42.19%	3065.46%	-54.34%
Accounts Receivable	1,982	940.49	1,723	816.4	238.56
Other Receivables	8.82	5.63	7.17	0.83	0.03
Receivables	1,990	946.12	1,730	817.23	238.59
Inventory	2,066	1,825	1,786	849.23	375.73
Prepaid Expenses	50.18	24.58	20.66	8.42	0.76
Restricted Cash	1,254	2,800	1,822	1,376	441.5
Other Current Assets	1,448	1,408	320.1	305.86	221.09
Total Current Assets	26,453	22,470	13,638	8,955	1,455
Property, Plant & Equipment	6,274	4,601	4,028	2,383	1,639
Long-Term Investments	4,339	837.96	368.6	35.77	158.58
Other Intangible Assets	450.11	449.68	446.63	419.87	19.85
Other Long-Term Assets	130.51	95.24	786.08	732.59	-
Total Assets	37,647	28,453	19,268	12,526	3,272
Accounts Payable	18,903	9,858	5,987	2,596	738.94
Accrued Expenses	2,554	1,482	1,201	597.08	175.79
Short-Term Debt	1,000	850.5	300	-	1,155
Current Portion of Long-Term Debt	237.85	416.03	468.53	340.17	87.92
Current Portion of Leases	173.35	418.77	399.18	24.56	13.38
Current Income Taxes Payable	235.35	89.42	27.85	11.91	8.96
Current Unearned Revenue	161.42	22.56	31.23	3.73	-
Other Current Liabilities	1,709	816.36	843.03	755.97	236.18
Total Current Liabilities	24,975	13,954	9,257	4,330	2,416
Long-Term Debt	1,108	863.94	523.28	534.02	1,159
Long-Term Leases	186.95	197.37	518.93	16.36	13.79
Long-Term Unearned Revenue	633.67	572.1	531.48	360.93	239.78
Other Long-Term Liabilities	671.88	368.1	177.93	55.43	6.08
Total Liabilities	27,576	15,955	11,009	5,296	3,835
Common Stock	1,337	1,337	1,143	1,012	-
Additional Paid-In Capital	23,555	23,555	15,983	10,520	538.98
Retained Earnings	-16,717	-13,897	-9,680	-4,571	-2,707
Comprehensive Income & Other	1,896	1,502	813.18	269.81	1,604
Shareholders' Equity	10,071	12,498	8,259	7,230	-563.2
Total Liabilities & Equity	37,647	28,453	19,268	12,526	3,272
Total Debt	2,707	2,747	2,210	915.11	2,429
Net Cash (Debt)	16,938	12,720	5,750	4,683	-2,252
Net Cash Growth	33.17%	121.22%	22.78%	-	-
Net Cash Per Share	12.67	10.92	5.50	4.98	-6.13
Filing Date Shares Outstanding	1,337	1,337	1,143	1,012	367.67
Total Common Shares Outstanding	1,337	1,337	1,143	1,012	367.67
Working Capital	1,478	8,516	4,381	4,625	-961.64
Book Value Per Share	7.53	9.35	7.23	7.15	-1.53
Tangible Book Value	9,621	12,049	7,812	6,810	-583.05
Tangible Book Value Per Share	7.20	9.01	6.84	6.73	-1.59
Buildings	856.22	630.38	538.16	527.24	523.42
Machinery	3,591	2,897	2,444	1,227	1,017
Construction In Progress	2,274	1,287	788.01	548.85	181.01
Leasehold Improvements	164.34	106.16	-	20.29	14.79

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.